Ireland: New drug price deal to save over €400 million - (RTE News via NewsPoints Desk)

  • An agreement has been reached between the pharmaceutical industry and the Irish government on drug prices, which is expected to yield savings of over 400 million euros, as reported RTE News on Monday.
  • The three-year agreement between the Irish Pharmaceutical Healthcare Association (IPHA), the Department of Health and HSE will reduce spending on medicines in various schemes.
  • Under the agreement, when a patent expires on a medicine, the price to the wholesaler will be reduced to 70 percent of the original price and a year later it will be reduced to 50 percent of the original price.
  • For existing expired medicines, the price to the wholesaler will be reduced to 60 percent of the original price from November 1 and a year later it will be reduced to 50 percent of the original price.
  • Under the Health Pricing and Supply of Medical Goods Bill 2012, a pharmacist will be able to dispense a generic version of a medicine when a specific brand has been prescribed, but if the patient wants a branded version they will pay the difference.
  • The Bill will enable the HSE to list medicines or other items that are to be provided under the medical card or drug payment scheme and will be able to attach conditions to the supply or reimbursement of items based on cost-effectiveness, patient safety and other factors.

To read more NewsPoints articles, click here.

Reference Articles